SEED
Founded in 1957, SEED is Japan’s largest manufacturer of disposable contact lenses. The company began contact lens research in 1951 and has been providing contact lenses, care products, and spectacles in Japan for more than 50 years. SEED is dedicated to making safe and comfortable contact lenses for everyone.
Today, SEED is expanding internationally. Its products are available across Asia, including China, Hong Kong, Macau, Taiwan, Singapore, Malaysia, Vietnam, the Philippines, Indonesia, Mongolia, and India, as well as in several European countries such as the Nordics, Italy, Switzerland, Portugal, and the Netherlands. In 2018, SEED acquired UltraVision CLPL to grow its presence in the UK and Ireland.
Other relevant products
The following product(s) have not been specifically designed for myopia control and/or do not have regulatory approval for the same, but are listed by Myopia Profile as they have randomized controlled trial research data supporting their efficacy for myopia management. Suitability for prescribing these treatments will depend on your country and regulatory requirements of practice, and also be aware that not all products are available in all countries.
Seed 1dayPure EDOF
SEED 1dayPure EDOF is a daily disposable soft contact lens made in Japan. It was developed with the Brien Holden Vision Institute and uses Extended Depth-of-Focus (EDOF) technology to give clear vision at all distances while reducing ghosting and halos. The lens was designed to support both early myopia management and presbyopia, offering a smooth visual experience for everyday activities. Its effectiveness for myopia management has been tested in a 12-month clinical trial.
SEED resources
Myopia Awareness Video
This video provides an essential overview of childhood myopia—what it is, why it matters, and how it can be managed. Hear expert insights from Dr. Kah Ooi Tan, President of the Asia Optometric Management Academy, and Dr. Sayuri Ninomiya, Director of Itami Central Eye Clinic in Hyogo, Japan. Together, they explore the growing global concern of childhood myopia, discussing its risks, underlying mechanisms, and the importance of early intervention. Dr. Tan provides an overview of current myopia control treatment methods, while Dr. Ninomiya shares her clinical perspective and experience in managing myopic progression in children.